Search

Molecule Partner With VitaDAO to Create Biopharma IP-to-NFT Transfer Using Nevermined Solution

19.8.2021
PRESS RELEASE. Molecule, a decentralised biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics...